FIELD: ophthalmology.
SUBSTANCE: invention is intended to prevent or treat visual impairment. For the prevention or treatment of visual impairment, such as macular degeneration, glaucoma or diabetic retinopathy, a composition containing the active ingredients is used: (a) ursodeoxycholic acid (UDCA) selected from ursodeoxycholic acid, taurosodeoxycholic acid and glycoursodeoxycholic acid; (b) a water-soluble starch conversion product, wherein the pH of said composition is 6.5-8. The water-soluble starch conversion product is maltodextrin. The minimum mass ratio of ursodeoxycholic acid and maltodextrin is 1: 13-1: 25. The specified composition is prepared for intravitreal injection. A single dose of UDCA for intravitreal injection is 50-100 μl at a concentration of 0.1-1.5 mg / ml.
EFFECT: use of the invention provides an excellent effect of preventing or treating visual impairment diseases such as macular degeneration, glaucoma and diabetic retinopathy.
8 cl, 24 dwg, 9 tbl, 12 ex
| Title |
Year |
Author |
Number |
| COMPOSITION FOR PREVENTING OR TREATING VISION DISORDERS, CONTAINING URSODEOXYCHOLIC ACID |
2018 |
|
RU2723988C1 |
| METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION |
2009 |
- Robinson Majkl R.
- Blanda Uendi M.
- Khyus Patrik M.
- Berke Dzhejms A.
- Vitkap Skott M.
|
RU2668371C2 |
| METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION |
2009 |
- Robinson Majkl R.
- Blanda Uehndi M.
- Kh'Jus Patrik M.
- Berke Dzhehjms A.
- Vitkap Skott M.
|
RU2521338C9 |
| TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS |
2018 |
- Hopkins, Jill
- Tsuruda, Pam
- Chapman, Claude
- Sweigard, Harry
- Poon, Yan
- Marquess, Daniel
- David, Nathaniel
- Dananberg, Jamie
- Laberge, Remi-Martin
|
RU2815482C2 |
| NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT |
2019 |
- Olmiere, Celine
- Mercier, Fabrice
|
RU2806096C2 |
| APPLICATION OF ANTAGONIST VEGF IN TREATMENT OF CHORIORETINAL NEOVASCULAR DISTURBANCES AND DISORDERS OF PENETRATION IN PEDIATRIC PATIENTS |
2014 |
- Aksenov Sergej
- Buryan Gabriela
|
RU2676274C2 |
| NEUROPROTECTIVE ACTION OF SOLUBLE URSODEOXYCHOLIC ACID IN MODELS OF FOCAL ISCHEMIA |
2005 |
|
RU2428987C2 |
| PEPTIDES FOR INHIBITING ANGIOGENESIS |
2016 |
- Komarova Yulia A.
- Rosenblatt Mark
- Malik Asrar B.
|
RU2708375C2 |
| SIRNA AND THEIR USE IN METHODS AND COMPOSITIONS FOR INHIBITING NRARP GENE EXPRESSION |
2016 |
- Jimenez, Ana Isabel
- Paneda, Covadonga
- Martinez, Tamara
|
RU2738971C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED |
2016 |
- Kim, Seong Beom
- Jung, Hyei Yoon
- Yang, Seok Woo
- Kwon, Hyuk Sang
- Kang, Jae-Hoon
|
RU2712623C2 |
